account_id none on file
legal_name Gain Therapeutics, Inc.
ticker GANX
cik 1819411
domain gaintherapeutics.com
linkedin_company_url https://www.linkedin.com/company/gain-therapeutics/
entry_point_account_id none on file
name Gain Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 4 executives 3 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include legal fees relating to patent and corporate matters, professional fees for accounting, auditing, tax and consulting services, insurance costs, travel expenses, and facility-related expenses, and other operating costs.
filing / Aug 11, 2026 / receipt
● fees paid to consultants who assist with research and development activities and related travel expenses; and ● the cost of sponsored research, which includes laboratory materials and supplies, manufacturing scale-up expenses and the cost of acquiring and manufacturing preclinical studies.
filing / Aug 11, 2026 / receipt
General and administrative expenses also include legal fees relating to patent and corporate matters, professional fees for accounting, auditing, tax and consulting services, insurance costs, travel expenses, and facility-related expenses, and other operating costs.
filing / May 11, 2026 / receipt
● fees paid to consultants who assist with research and development activities and related travel expenses; and ● the cost of sponsored research, which includes laboratory materials and supplies, manufacturing scale-up expenses and the cost of acquiring and manufacturing preclinical studies.
filing / May 11, 2026 / receipt
executives
| Gene Mack | Chief Executive Officer | - | receipt |
| Gianluca Fuggetta | Senior Vice President Finance | Principal Financial Officer | receipt | |
| Matthias Alder | Chief Operating Officer | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changes
| 2024-04-08 | Chief Financial Officer, appointed | sec_8k |
| 2024-02-22 | Vice President, appointed | sec_8k |
| 2022-12-16 | Principal Accounting Officer, appointed | sec_8k |
| 2021-10-20 | Chief Operating Officer, appointed | sec_8k |
mcp_package_hint
slug gain-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$